News Conference News NY Valves 2025 Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication Todd Neale June 27, 2025
News Conference News NY Valves 2025 Long-term Survival Better With TAVI Explant vs Redo: Medicare Data Yael L. Maxwell June 26, 2025
News Conference News NY Valves 2025 Alerts to Physicians Close Gaps in AS Management Between Women, Men Todd Neale June 25, 2025
News Conference News NY Valves 2024 Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR Todd Neale June 14, 2024
News Conference News NY Valves 2024 National Data Point to Soaring TAVI Rates in Patients Under 65 Michael O'Riordan June 14, 2024
Presentation NY Valves 2024 UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS Presenter: Philippe Pibarot June 07, 2024
Presentation NY Valves 2024 Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials Presenter: Nicolas M. Van Mieghem June 06, 2024
Presentation NY Valves 2024 Why Favor Redo SAVR After a Failed Bioprosthetic AVR? Presenter: Tsuyoshi Kaneko June 06, 2024
Presentation NY Valves 2024 Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients Presenter: Parag Goyal June 05, 2024